![Dale Zajicek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Dale Zajicek served as President of BioVectra, Inc. from 2011 to 2015.
He also worked as an Independent Director for Oncolix, Inc. and held various titles at the same company from 2017 to 2019.
Zajicek received his undergraduate degrees from Illinois Institute of Technology and Elmhurst College.
Precedenti posizioni note di Dale Zajicek
Società | Posizione | Fine |
---|---|---|
ONCOLIX, INC. | Direttore/Membro del Consiglio | 06/03/2019 |
BioVectra, Inc.
![]() BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Presidente | 01/01/2015 |
Oncolix, Inc. /Old/
![]() Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | - |
Formazione di Dale Zajicek
Illinois Institute of Technology | Undergraduate Degree |
Elmhurst College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
BioVectra, Inc.
![]() BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Health Technology |
Oncolix, Inc. /Old/
![]() Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
Oncolix, Inc.
![]() Oncolix, Inc. Pharmaceuticals: MajorHealth Technology Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- Dale Zajicek